Understanding Nutrition While Using GLP-1 Medications Like Ozempic and Mounjaro
Around half a million Australians are currently using GLP-1 medications for diabetes, with an even larger number using them for obesity and related health conditions. GLP-1s, including semaglutide (known as Ozempic or Wegovy) and tirzepatide (Mounjaro), have proven effective in managing diabetes and obesity. However, these medications can lead to gastrointestinal side effects and nutritional deficiencies due to reduced food intake.
When consuming food, the body produces appetite hormones such as GLP-1 and GIP (glucose-dependent insulinotropic polypeptide). These hormones are typically active for only a few minutes, but GLP-1 medications are designed to resist breakdown, allowing for weekly injections. Studies show that adults with type 2 diabetes or obesity can lose an average of 6.24 kilograms more than those on placebo when taking semaglutide (1mg weekly), and up to 10.8 kilograms more with tirzepatide (15mg weekly).
The amount of weight loss varies based on individual health, medication, dosage, and treatment duration. In studies lasting over a year, weight loss is reported as a percentage of starting body weight. For instance, individuals taking a 2.4mg weekly dose of semaglutide lost an average of 10.2% of their body weight, while those on a 7.2mg dose lost about 12.6%. For tirzepatide, weight losses were recorded at 9.5% for a 5mg dose, 12.4% for a 10mg dose, and 14.8% for a 15mg dose. Users generally experience improved health and quality of life with more than 5% weight loss, but higher doses may cause more side effects and require careful management.
Nausea is the most commonly reported side effect associated with GLP-1 use, affecting about 21% of users according to a review of over 33,000 individuals. Other gastrointestinal issues include diarrhea (10%), vomiting (9%), indigestion (9%), and constipation (8%). While these rates may seem low, the unpleasant nature of these side effects can lead to discontinuation of the medication, resulting in a return to baseline body weight and related health risks.
Understanding the Nutritional Risks Associated with GLP-1 Medications
Less common side effects include reflux, flatulence, abdominal pain, and even acute pancreatitis. These side effects can affect the absorption of oral contraceptives in women, leading to unintended pregnancies. Nutritional deficiencies may arise from significant reductions in food intake, especially if rapid weight loss occurs due to GLP-1 use. For example, a few studies have shown that individuals on GLP-1 medications may consume 25-33% fewer kilojoules during meals, increasing the risk of malnutrition.
Monitoring Nutritional Health While Using GLP-1 Medications
Signs of nutrient deficiencies can manifest in various ways, and it's essential to monitor dietary intake. Keeping a food diary can help identify whether nutrient needs are being met. A balanced diet should include adequate protein, fiber, vitamins, and minerals. The Australian Guide to Healthy Eating can serve as a useful tool for meal planning. If you're experiencing appetite changes or gastrointestinal side effects while on GLP-1 medications, consulting a dietitian can provide personalized guidance to improve your nutritional health.
For more information on specific nutrients and recipes to enhance your dietary intake, resources are available online. If this article raises concerns or you know someone who may need support, consider reaching out to a local helpline for assistance.




